- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04387721
Influence of Residual Astigmatism on Visual Acuity in Patients Undergoing Cataract Surgery With Trifocal Intraocular Lens Implantation
MAIN OBJECTIVE: To assess the influence of residual astigmatism on visual acuity in the different lens foci in patients operated on for cataracts with a trifocal intraocular lens implant.
SECONDARY OBJECTIVE: To study the influence of residual astigmatism on the visual quality of the patient in the far focus and to determine if there are differences of affectation in the two study groups.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Barcelona, Spain, 08022
- Recruiting
- Clinica Oftalmológica TACIR
-
Contact:
- Ordiñaga-Monreal Enrique, OD
- Phone Number: 934179803
- Email: e.ordinaga@clinicatacir.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Bilateral surgery performed by the same surgeon
- IOLs implanted IOLs FineVision (MicroF) and FineVision Toric (PodFT)
- Patients with pre-surgery corneal astigmatism less than 2.5 D
- Patients whose pupillary diameter in physiological position (conditions of lower photopic pupil) not over 4 mm.
Exclusion Criteria:
- Post-surgical refractive residual astigmatisms ≧ 1.55D
- Previous corneal or intraocular surgeries
- Active diseases
- Eye complications during the 3-month follow-up
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Trifocal IOL(Finevision IOL, PhysIOL)
We will divide the sample into two groups of patients depending on the IOL implanted First group: FineVision
|
Patients will be divided between groups based on pre-surgery corneal astigmatism.
Group FineVision is made up of patients with corneal astigmatism less than 1 D. Groups FineVision Toric is made up pf patients with corneal astigmatism more than 1.25 D
Other Names:
|
|
Trifocal toric IOL (Finevision Toric IOL, PhysIOL)
We will divide the sample into two groups of patients depending on the IOL implanted: Second group: FineVisionToric
|
Patients will be divided between groups based on pre-surgery corneal astigmatism.
Group FineVision is made up of patients with corneal astigmatism less than 1 D. Groups FineVision Toric is made up pf patients with corneal astigmatism more than 1.25 D
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Acuity
Time Frame: 3 months following cataract surgery
|
Visual acuity will be measured at distance, intermediate distance (67 cm) and near (40 cm).
Visual acuities will be obtained with logarithmic notation
|
3 months following cataract surgery
|
|
Contrast Sensitivity Function (CSF)
Time Frame: 3 months following cataract surgery
|
Contrast sensitivity will be measured at far, intermediate distance (67 cm) and near (40 cm).
|
3 months following cataract surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differences between groups
Time Frame: 3 months following cataract surgery
|
Results will be compared between groups.
|
3 months following cataract surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Enrique Ordiñaga-Monreal, OD, Clinica Oftalmológica TACIR
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EC042019
- 2019/65-OFT-CMT (Other Identifier: CEIm Grupo Hospitalario Quirónsalud-Catalunya)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Bausch & Lomb IncorporatedNot yet recruiting
-
London Vision ClinicOptana GmbHActive, not recruitingCorneal AstigmatismUnited Kingdom
-
Eye Hospital Pristina KosovoActive, not recruiting
-
Yonsei UniversityUnknownMyopic AstigmatismKorea, Republic of
-
Abbott Medical OpticsCompletedRefractive AstigmatismAustria
-
Ziemer Ophthalmic Systems AGTigermed Consulting Co., LtdRecruitingMyopic AstigmatismChina
-
Bausch & Lomb IncorporatedCompleted
-
CooperVision, Inc.CompletedAstigmatism BilateralCanada
-
University Clinic FrankfurtCompleted
Clinical Trials on Kind of trifocal IOL
-
Carl Zeiss Meditec AGCompleted
-
Peking University Third HospitalUnknown
-
Shanghai 10th People's HospitalActive, not recruiting
-
Bucci Laser Vision InstituteCompletedCataract | Patient Satisfaction | IOLUnited States
-
Maastricht University Medical CenterAbbott Medical OpticsCompletedCataract | PresbyopiaNetherlands
-
Peking University Third HospitalPeople's Hospital of GuangxiRecruitingPresbyopia | Cataract SenileChina
-
AST Products, Inc.Completed
-
ICARES Medicus, Inc.AST Products, Inc.Completed
-
Alcon ResearchCompletedCorneal Astigmatism | AphakiaJapan
-
Azienda Ospedaliera Universitaria Integrata VeronaCompletedCataract | Presbyopia CorrectionItaly